37 results about "Respiratory secretion" patented technology

An apparatus, system, and method for managing respiratory secretions and fluids in sections of artificial airways. In an embodiment of the invention, a respiratory secretion retention (RSR) device configured to fluidly connect to an artificial airway can be provided. The device can include a housing that defines a passageway for the flow of respiratory gases with at least two chambers coupled to the housing. The chambers are configured to retain exhaled respiratory particulate and liquid. The respiratory secretion retention device further includes a patient port coupled to the housing that is in fluid communication with the artificial airway and a repositionable barrier configured to isolate at least one of the two chambers from the passageway. In another embodiment, a secretion removal assembly can connect to a respiratory secretion retention device; the secretion removal assembly includes a connector configured for connecting to a port of the respiratory secretion retention device and a spike coupled to the connector.

A novel and non-obvious apparatus, system, and method for managing respiratory secretions and fluids in sections of artificial airways. In an embodiment of the invention, a respiratory secretion retention (RSR) device configured to fluidly connect to an artificial airway can be provided. The respiratory secretion retention (RSR) device can include a housing that defines a passageway for the flow of respiratory gases, a chamber defined by the housing with a portion of the chamber configured to retain exhaled respiratory particulate and liquid, a patient side port coupled with the housing, which is in fluid communication with an artificial airway and at least one access port coupled with the housing were the at least one access port includes a control valve. In an aspect of this embodiment, the housing further can include an instillation port.

The present invention involves an apparatus for implementing hydro-acoustic therapy for the lungs on a patient and a method for the hydro-acoustic therapy (HAT) for the lungs. The HAT apparatus includes a chamber filled with a fluid, particularly water. The HAT apparatus also has an acoustic generator for generating low frequency acoustic waves in the fluid. A patient is positioned in the chamber and partially submersed in the fluid for treatment. In another aspect, a method for implementing hydro-acoustic therapy for the lungs includes the step of placing a person in the apparatus described above such that a body of the person is immersed in said occurs. Then, introducing acoustic vibrations into the fluid. The vibrations, if properly tuned, cause the mobilization of respiratory secretions in the person.

A novel and non-obvious apparatus, system, and method for managing respiratory secretions and fluids in sections of artificial airways. In an embodiment of the invention, a respiratory secretion retention (RSR) device configured to connect to an artificial airway can be provided. The respiratory secretion retention (RSR) device can include a housing that defines a passageway for the flow of respiratory gases, a chamber that is defined by the housing, where a portion of the chamber is configured to retain exhaled respiratory particulate and liquid, and at least one element configured to provide for repositioning at least a portion of the housing with respect to the artificial airway. In an aspect of this embodiment, the at least a portion of the housing can be repositioned with respect to the artificial airway without opening the artificial airway to the atmosphere.

The invention provides an extraction-free method and a kit for qualitatively detecting SARS-CoV-2 by fluorescence polymerase chain reaction (fluorescence PCR), and belongs to the field of biotechnology and medicine. The method integrates sample nucleic acid release and amplification. The kit comprises a lysis solution and a rapid enzyme, can directly lyse and amplify respiratory secretions of a patient, make a whole detection process fast and simple, reduce chance of mutual contamination, obtain accurate and reliable PCR test results, can diagnose presence of SARS-CoV-2 in patient secretions as soon as possible, and has important application value in the fields of disease monitoring and clinical diagnosis.

The invention discloses a respiratory secretion sampling mask and particularly relates to a respiratory secretion sampling mask suitable for sampling respiratory secretion of a novel coronavirus pneumonia patient. The respiratory secretion sampling mask comprises a mask body, an induction module and a collection module are arranged on the mask body, the induction module is used for inducing a patient to generate respiratory reflex, and the collection module is used for collecting secretion discharged by the respiratory reflex of the patient.

The invention relates to newborn severe pneumonia treatment and nursing equipment which comprises a box body and a box cover; a ventilation filter and a temperature and humidity regulator are arrangedin the box body, and the newborn severe pneumonia treatment and nursing equipment is characterized in that a body position adjusting device and a respiratory tract secretion removing device are further arranged in the box body; in the body position adjusting device, a cushion frame is mounted in the box body, a head cushion body is arranged at the head of the cushion frame, a left movable cushionbody and a right movable cushion body are arranged at a middle upper part of the cushion frame, a left mounting cavity and a right mounting cavity which are bilaterally symmetrical are formed in thecushion frame, the left movable cushion body and the right movable cushion body are respectively mounted in the left mounting cavity and the right mounting cavity, and a fixed cushion body is arrangedbelow the cushion frame; a negative pressure sputum suction mechanism in a respiratory tract secretion removing device is arranged on the outer side of the head of the box body, and a sputum suctionpipe in the negative pressure sputum suction mechanism stretches into the box body. The body position of a child patient can be changed frequently, pulmonary congestion is relieved, pulmonary atelectasis is prevented, secreta of the upper respiratory tract of the child patient can be removed in time, dyspnea is relieved, and the anaerobic condition is improved.

A tissue tester for providing an indication of the presence of disease including a first paper tissue sheet; and a filter patch treated with a color changing indicator affixed to the first paper tissue sheet. The tester may also consist of a single sheet of filter paper treated with a solution of turmeric and alcohol. The color indicator changes from yellow to brown when disease is indicated in respiratory secretions.

The invention relates to a bronchoscope lower respiratory secretion collection bottle. The bronchoscope lower respiratory secretion collecting bottle comprises the collecting bottle, a first drainage pipe, a second drainage pipe, an upper bottle cover and a lower bottle cover; a bottle opening of the collecting bottle is open; a bottle bottom is sealed; the upper bottle cover and the lower bottle cover are respectively screwed at the bottle opening and the bottle bottom; the two drainage pipes are inserted into the collecting bottle from the upper bottle cover; the first drainage pipe is connected with an aspirator; the second drainage pipe is connected with a bronchoscope suction inlet; the integral device which is in a sealed type structure performed bacteria-free processing. Compared with the prior art, the bronchoscope lower respiratory secretion collecting bottle which is a sealed bacteria-free bottle and provided with a two-way device has the advantages of being simple in structure and convenient to operate, enabling intro-lung lavage fluid or respiratory secretions to be directly recycled, guaranteeing recycled materials not being polluted and improving the bacteria positive rate.

The present invention provides a method for distinguishing bacterial from non-bacterial exacerbations of chronic lung disease. The method comprises detecting the presence of elastase in patient sputum containing secretions of the lower respiratory tract.

The invention provides a respiratory secretion collecting device and belongs to the field of manufacturing of medical supplies. The respiratory secretion collecting device comprises an elastic face mask adopting a semispherical structure; a liquid joint is arranged on the bulging side of the face mask, and a collecting bottle is mounted at the liquid joint; and a casing penetrating through the elastic face mask is also arranged on the elastic face mask, and a plastic fiber strip capable of being pulled is arranged in the casing in a sleeved manner. The mouth and nose parts of a person are shielded by the elastic face mask, and then, the plastic fiber strip is controlled by pulling to irritate nasal mucosa to cause sneezing, so that secretions at deep parts of a respiratory system are sprayed onto the face mask at a high speed and then collected by the collecting bottle, and detection and test are facilitated.

The invention discloses an oropharyngeal respiratory secretion suction device, which comprises a liquid storage bag, a discharging mechanism fixedly penetrates through the bottom of the liquid storage bag in a sealed mode, an exhaust mechanism fixedly penetrates through the top of the liquid storage bag in a sealed mode, a liquid discharging mechanism is fixedly arranged in the exhaust mechanism, and a liquid suction mechanism is arranged outside the exhaust mechanism in a threaded and sleeving mode. A rubber pad slidably sleeves the liquid absorption mechanism, an application is fixedly arranged at the top of the rubber pad, the liquid absorption mechanism is sleeved with the application, a medical adhesive tape is arranged at the bottom of the rubber pad, and one end of the inner side of the medical adhesive tape is fixedly connected with the rubber pad. According to the device, secretions in the oropharyngeal respiratory tract of a patient can be located in an independent extraction space, so that medical staff can conveniently move the extracted and collected secretions to a detection area, and therefore, by using the device, the extraction effect of the secretions is improved, and the effect of subsequently inspecting the extracted secretions by medical staff is also ensured.

The invention discloses a respiratory tract secretion collection simulation training and examination system and device. The system comprises a login module; a mode selection module which is used for selecting a theory teaching mode, a theory assessment mode, a training mode and an operation assessment mode; a theory teaching module which is used for teaching theoretical knowledge; a theory assessment module which is used for assessing the learned theoretical knowledge; a training module which is used for training the part for collecting the nasal secretions and the collection time, and the part for collecting the pharyngeal secretions and the collection time; an operation checking module which is used for checking; a human head model, a nasal cavity detection assembly, a pharynx detection assembly and a communication module are arranged in the human head model, and the human head model is used for achieving communication with terminal equipment and achieving data transmission among the modules. The beneficial effects of the invention are that a practicer can perform assessment on the basis of sufficient training, and learning and assessment are divided into theoretical knowledge and operation steps, so that learning and assessment are more comprehensive.

The invention discloses a culture medium and fermentation culture method used for high-density culture of mycoplasma capricolumsubsp. capripneumonia. The mycoplasma capricolumsubsp. capripneumonia isisolated from respiratory secretions of a goat clinically diagnosed with mycoplasmal pneumonia; the mycoplasma capricolumsubsp. capripneumonia has been collected in China General Microbiological Culture Collection Center on 4 December, 2019, and the collection number is CGMCC No.18878; according to the fermentation culture method, liquid fermentation culture is carried out on the resuscitated-passaging mycoplasma capricolumsubsp. capripneumonia ZFY17 CGMCC No.18878 in a specific fermentation culture medium under specific conditions; and the specific fermentation culture medium replaces part ofhorse serum with a combination of glucose, hydrolyzed yeast protein, a hydrolyzed yeast culture, lactoalbumin hydrolysate and casein, thus greatly reducing strain fermentation cost.

The invention discloses a nursing pharmaceutical composition used before operative anesthesia and a preparation method of the nursing pharmaceutical composition. The composition comprises the following components in parts by weight: 0.08-0.15 part of sucralose modified atropine taurate, 2-4 parts of a Chinese chive seed extract, 3-5 parts of a rhodobryum roseum extract, 2-5 parts of apigenin, 1-3parts of an achnatherum inebrians extract, 2-5 parts of a cotton rose hibiscus extract and 8-10 parts of a Chinese herbal medicine extract. The invention further provides the preparation method of thenursing pharmaceutical composition used before operative anesthesia. The nursing pharmaceutical composition used before operative anesthesia is small in toxic and side effect, good in medicine effectand low in dosage, can effectively relieve tension and anxiety of a patient, reduce secretion of saliva and respiratory tract secreta of the patient and prevent intraoperative and postoperative pulmonary complications, and can effectively improve the pain threshold of an operative patient after being applied before anesthesia.

The invention relates to a drug composition for preanesthesia operation nursing and application of the drug composition. The drug composition comprises Imidafenacin or medicinal drug thereof, tetrahydropalmatine and/or gentianine. Various components of the drug composition are synergistic after being combined, so that the application dose of a single component in the combination is reduced, the feeling threshold of the operation patient can be effectively improved, the dose of the anaesthetic for the operation can be reduced, the adverse effect caused by the anaesthetic can be effectively alleviated, the anxiety of the patient can be alleviated, saliva and respiratory secretions of the patient can be reduced, and the pulmonary complications in the operation and after the operation can be prevented; and therefore, the drug composition can be widely used for the preanesthesia operation nursing.

The invention discloses a specific primer, a probe and a kit for gene detection of a novel coronavirus. The kit comprises a novel coronavirus specific nucleic acid quantitative standard substance, a virus RNA extraction reagent and a fluorescence amplification detection reagent. In detection, plasma, whole blood, throat swab, mouthwash or respiratory tract secretion of an object to be detected isdirectly used as an analysis sample, RNA in the sample is extracted as a nucleic acid template, and fluorescence polymerase chain reaction amplification is carried out on a nucleic acid template chain. The detection method is quick and convenient, can detect whether the secreta or blood of the to-be-detected object has the novel coronavirus as soon as possible, and effectively reduces the propagation of the novel coronavirus in people.